B

BioVectra Inc.

387 employees

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.

Basic info

Industry

biotechnology

Sectors

Biotechnology
APIs
mPEG Reagents
Cytotoxic Handling Capabilites
GMP Custom Chemical Synthesis
DMF Regulations and Filings
Health Care
Speciality Processing Reagents
GMP Fermentation
Therapeutics
Manufacturing
Biomass extration and Purification

Date founded

1970

Funding rounds raised

Total raised

$40M

from 1 investors over 1 rounds

B

BioVectra Inc. raised $40M on November 18, 2021

Investors: Government of Canada (2 projects)

FAQ